(Q46814329)

25 December 2017

title

Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. (English)

1 reference

25 December 2017

0 references

Chris P Stephenson

1

1 reference

25 December 2017

Emily Karanges

series ordinal

2

1 reference

25 December 2017

Iain S McGregor

series ordinal

3

1 reference

25 December 2017

publication date

9 November 2012

1 reference

25 December 2017

Australian and New Zealand Journal of Psychiatry

published in

1 reference

25 December 2017

volume

47

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

74-87

1 reference

25 December 2017

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Supping with the devil? The dangers of liaisons between pharma and our profession.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in medication treatment for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antidepressant drug effects and depression severity: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Novel melatonin-based therapies: potential advances in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antiepileptic drugs in Australia: 2002-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Anxiolytic, hypnotic and sedative medication use in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Patterns of antipsychotic medication use in Australia 2002-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Australian national trends in stimulant dispensing: 2002-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Changes in psychological distress in Australian adults between 1995 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Withdrawing Benzodiazepines in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in psychotropic medication polypharmacy in office-based psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

The role of alprazolam for the treatment of panic disorder in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Is depression overdiagnosed? Yes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Public attitudes towards the acceptability of using drugs to treat depression and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

The global market for ADHD medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

For richer, for poorer, in sickness and in health: the entanglement of science and marketing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Sifting the evidence-what's wrong with significance tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Trends in utilization of antiepileptic drugs in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Tolerability and safety of fluvoxamine and other antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

Stimulant medication use in children: a 12-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412466595

21 January 2018

Identifiers

DOI

10.1177/0004867412466595

1 reference

25 December 2017

1 reference

25 December 2017